Plain-English translation of NCT06631820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a small pilot study testing whether (-)‐Epicatechin, a natural compound found in cacao and green tea, can help improve muscle health in people with advanced chronic kidney disease. The study will look at whether this medication can help prevent muscle loss and weakness, which are common problems for kidney disease patients. Researchers want to see if this treatment might help people stay stronger and more independent.
People with advanced kidney disease often lose muscle mass and strength, which increases their risk of falls, infections, hospitalization, and loss of independence. Current treatments don't adequately address this problem, so researchers are testing whether this natural compound—which has shown promise in earlier studies for building muscle and improving energy production in muscle cells—might help.
You likely qualify if…
You likely don't qualify if…
You would first spend 8 weeks as part of a control group, where you don't take anything new—this gives researchers a baseline to compare against. Then, for the next 8 weeks, you would take the supplement daily. During the study, you'll have blood tests and muscle assessments to see how the treatment affects your muscle strength, muscle quality, and muscle-related markers in your blood.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Sweden